Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000961207 | SCV001108244 | likely benign | Mucolipidosis type IV | 2024-01-28 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000961207 | SCV001290712 | likely benign | Mucolipidosis type IV | 2017-08-01 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. |
Genome- |
RCV000961207 | SCV001805942 | likely benign | Mucolipidosis type IV | 2021-07-14 | criteria provided, single submitter | clinical testing | |
Gene |
RCV003148900 | SCV003837305 | uncertain significance | not provided | 2024-09-07 | criteria provided, single submitter | clinical testing | In silico analysis indicates that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |
Breakthrough Genomics, |
RCV003148900 | SCV005210617 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Natera, |
RCV000961207 | SCV001460352 | likely benign | Mucolipidosis type IV | 2020-05-04 | no assertion criteria provided | clinical testing | |
Prevention |
RCV003943107 | SCV004761076 | likely benign | MCOLN1-related disorder | 2022-03-09 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |